Content about pharmaceutical

September 24, 2012

McKesson on Monday named Mark Walchirk president of its U.S. pharmaceutical division, effective immediately.

SAN FRANCISCO — McKesson on Monday named Mark Walchirk president of its U.S. pharmaceutical division, effective immediately. Walchirk, who most recently was chief operating officer of McKesson Specialty Health, has held numerous leadership roles at McKesson over the past 11 years, including COO of McKesson U.S. Pharmaceutical.

September 21, 2012

The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said at the wholesaler's ThinkLive Manufacturer's Summit.

PHILADELPHIA — The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said last week at the wholesaler's ThinkLive Manufacturer's Summit held here. "Next year is a slower brand-to-generic [trend] and in 2014 we’re going to see a resumption in that top-line growth rate [across the pharmaceutical industry in the U.S.] to a modest 4% growth," Collis said. "That’s not too bad," he added, especially when you compare that growth up against what's happening worldwide.

September 20, 2012

Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million.

LONDON — Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million. On completion of the transaction, which is subject to various regulatory approvals, Alliance Boots will be the second largest shareholder in Nanjing Pharmaceutical with board and operational management representation.

September 18, 2012

A trillion of anything is difficult to wrap one’s head around, whether it’s the number of grains of sand on a beach or stars in the sky. It’s so much easier for the human mind to look at such a quantity as the sum of its parts rather than on the basis of its individual components.


A trillion of anything is difficult to wrap one’s head around, whether it’s the number of grains of sand on a beach or stars in the sky. It’s so much easier for the human mind to look at such a quantity as the sum of its parts rather than on the basis of its individual components.


September 18, 2012

2012 is turning out to be a pretty important year for generic drugs, important enough that some of the things happening over the past several months have begged comparison to 1984, probably the biggest milestone year for the industry.


2012 is turning out to be a pretty important year for generic drugs, important enough that some of the things happening over the past several months have begged comparison to 1984, probably the biggest milestone year for the industry.


September 18, 2012

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals.

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals — reducing costs for health plans, payers and patients; scrambling drug makers’ balance sheets; and potentially boosting both drug utilization and adherence rates as reduced out-of-pocket costs induce more patients to fill their prescriptions.


September 10, 2012

H. D. Smith, one of the nation’s largest pharmaceutical wholesalers, on Monday named Timothy Booth to corporate VP and head of its home healthcare division.

SPRINGFIELD, Ill. — H. D. Smith, one of the nation’s largest pharmaceutical wholesalers, on Monday named Timothy Booth to corporate VP and head of its home healthcare division. Booth will report to Christopher Smith, H. D. Smith's president and COO.

September 4, 2012

Rx Response, an initiative of America’s biopharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, moved to its highest alert status last week as Hurricane Isaac made landfall in Louisiana and across the Gulf Coast.

WASHINGTON — Rx Response, an initiative of America's biopharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, moved to its highest alert status last week as Hurricane Isaac made landfall in Louisiana and across the Gulf Coast.

August 30, 2012

Generic drug maker Hospira has acquired a manufacturing and research and development center from an Indian drug maker for $200 million, Hospira said Wednesday.

LAKE FOREST, Ill. — Generic drug maker Hospira has acquired a manufacturing and research and development center from an Indian drug maker for $200 million, Hospira said Wednesday.

Hospira said it bought the Food and Drug Administration-approved active pharmaceutical ingredient factory and R&D facility in Aurangabad, India, from Orchid Chemicals and Pharmaceuticals, saying it would reduce Hospira's costs, support its supplying of antibiotics and pave the way for future API development.

August 27, 2012

AccentHealth’s Andrew Schulman, VP marketing, recently sat down with DSN to talk about a new regular DSN feature debuting in this issue called “Patient Views,” and how this series of surveys can help inform pharmacy operators and healthcare suppliers alike.


AccentHealth’s Andrew Schulman, VP marketing, recently sat down with DSN to talk about a new regular DSN feature debuting in this issue called “Patient Views,” and how this series of surveys can help inform pharmacy operators and healthcare suppliers alike.


DSN: What is AccentHealth, and why should retail pharmacy, pharmaceutical manufacturers and consumer packaged goods companies pay attention?


August 7, 2012

A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

INDIANAPOLIS — A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

July 30, 2012

How can Congress plug the leaks in the pharmaceutical supply chain and dry up the stream of gray market drugs without making the current drug shortage even worse? And can federal regulators shut down gray market profiteers without limiting “the ability of pharmacies to take care of their patients?”

How can Congress plug the leaks in the pharmaceutical supply chain and dry up the stream of gray market drugs without making the current drug shortage even worse? And can federal regulators shut down gray market profiteers without limiting “the ability of pharmacies to take care of their patients?”

July 26, 2012

The Senate Committee on Commerce, Science and Transportation on Wednesday released a staff report on the investigation into the gray market for pharmaceuticals — what the committee defined as "shady operators who make enormous profits by buying hard-to-find drugs and reselling them at huge markups" — specifically naming pharmacies as a primary culprit.

WASHINGTON — The Senate Committee on Commerce, Science and Transportation on Wednesday released a staff report on the investigation into the gray market for pharmaceuticals — what the committee defined as "shady operators who make enormous profits by buying hard-to-find drugs and reselling them at huge markups" — specifically naming pharmacies as a primary culprit.

July 23, 2012

Healthcare providers in today’s environment are committed to promoting patient safety while providing access to the most reliable and innovative treatments. Medication reconciliation, which is defined by The Joint Commission as “the process of comparing a patient’s medication orders to all of the medications that the patient has been taking,” is designed to prevent drug-related errors — including adverse interactions, overdoses or allergic reactions — and can assist healthcare providers, especially during care transitions when patients are most likely to receive new medications or alternative doses.

Healthcare providers in today’s environment are committed to promoting patient safety while providing access to the most reliable and innovative treatments.

July 20, 2012

The Council for Responsible Nutrition announced it is hosting a free webinar on the interaction between dietary supplements and pharmaceutical drugs via the professional networking website Pharmacist Society, an online community created by Skipta and sponsored by The Drug Store News Group, and Generation NP, a website that serves nurse practitioners.

WASHINGTON — The Council for Responsible Nutrition announced it is hosting a free webinar on the interaction between dietary supplements and pharmaceutical drugs via the professional networking website Pharmacist Society, an online community created by Skipta and sponsored by The Drug Store News Group, and Generation NP, a website that serves nurse practitioners.

This webinar is part of CRN’s ongoing initiative to help ensure that healthcare practitioners have access to science-based information on dietary supplements and the supplement industry.

July 18, 2012

Researchers argue there is compelling evidence that the recommended dietary allowance of vitamin C should be raised to 200 mg per day for adults, up from its current levels of 75 mg for women and 90 mg for men, in a recent report published in Critical Reviews in Food Science and Nutrition.

CORVALLIS, Ore. — Researchers argue there is compelling evidence that the recommended dietary allowance of vitamin C should be raised to 200 mg per day for adults, up from its current levels of 75 mg for women and 90 mg for men, in a recent report published in Critical Reviews in Food Science and Nutrition.

The recommended dietary allowance of vitamin C is less than half what it should be, according to the researchers, because medical experts insist on evaluating vitamin C in the same way they do pharmaceutical drugs and reach faulty conclusions as a result.

July 16, 2012

Walgreens and Alliance Boots — it’s a trans-Atlantic retail pharmacy game-changer. 


Walgreens and Alliance Boots — it’s a trans-Atlantic retail pharmacy game-changer. 


As the largest single purchaser of prescription drugs in the world, with 11,000 retail pharmacies in 12 countries that currently dispense more than 260 million prescriptions a year, and a global pharmaceutical wholesale operation to match, serving more than 180,000 healthcare outlets worldwide, the new company will have a whole lot more leverage on that side of the business. 


July 16, 2012

Is the reauthorization of the Prescription Drug User Fee Act “the most important pharmaceutical legislation since the 1984 Hatch-Waxman Act?”

Is the reauthorization of the Prescription Drug User Fee Act “the most important pharmaceutical legislation since the 1984 Hatch-Waxman Act?”

The generic drug industry’s chief spokesman and top lobbyist says so, at any rate. Ralph Neas, president and CEO of the Generic Pharmaceutical Association, called the newly enacted Food and Drug Administration Safety and Innovation Act “a remarkable achievement for patients, industry and the FDA.”

July 9, 2012

Merz has promoted one of its executives to serve as VP and chief compliance officer.

GREENSBORO, N.C. — Merz has promoted one of its executives to serve as VP and chief compliance officer.

The company said Katrina Church, who joined the company in November 2009, now will be responsible for providing strategic and operational leadership relating to compliance issues. Church officially took on the new responsibilities July 1.

June 26, 2012

With some 3,000 stores now under its banner coast to coast and official designation by JD Power & Associates as the nation’s favorite pharmacy service provider, Health Mart has achieved a remarkable growth record in the eight years since McKesson launched a top-to-bottom overhaul of the Health Mart brand and marketing strategy. Now, the nation’s top name in independent franchised pharmacy is stepping up to a new level of customer care, operating performance, marketing sophistication and technological prowess.

With some 3,000 stores now under its banner coast to coast and official designation by JD Power & Associates as the nation’s favorite pharmacy service provider, Health Mart has achieved a remarkable growth record in the eight years since McKesson launched a top-to-bottom overhaul of the Health Mart brand and marketing strategy. Now, the nation’s top name in independent franchised pharmacy is stepping up to a new level of customer care, operating performance, marketing sophistication and technological prowess.

June 25, 2012

The U.S. pharmaceutical subsidiary of Eisai has promoted one of its executives.

WOODCLIFF LAKE, N.J. — The U.S. pharmaceutical subsidiary of Eisai has promoted one of its executives.

Shaji Procida, who previously served as VP finance of Eisai Inc., has been appointed to serve as VP and CFO. In her elevated role, she will have oversight and responsibility for all of Eisai's financial operations in the United States and also will continue to serve as a member of the company's executive committee. Procida has worked at the drug maker since 1998.

June 21, 2012

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention.

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.


June 21, 2012

Drug Store News recently talked with COPD Foundation founder and president John Walsh about the organization’s new leadership. In March, the COPD Foundation took over leadership for Drive4COPD, which aims to screen people for chronic obstructive pulmonary disease, a collective term for emphysema and chronic bronchitis, which the group estimates to affect 24 million Americans who may have it but don’t know it.


Drug Store News recently talked with COPD Foundation founder and president John Walsh about the organization’s new leadership. In March, the COPD Foundation took over leadership for Drive4COPD, which aims to screen people for chronic obstructive pulmonary disease, a collective term for emphysema and chronic bronchitis, which the group estimates to affect 24 million Americans who may have it but don’t know it.


DSN: What led the COPD Foundation to take over Drive4COPD?


June 21, 2012

As much as CVS created a category of one for itself with its vertically integrated retail pharmacy-pharmacy benefit manager-clinic model, Walgreens has cast itself in a category of its own: A pharmacy-driven, global health-and-wellness company with the purchasing strength of more than 11,000 stores.

WHAT IT MEANS AND WHY IT'S IMPORTANT — As much as CVS created a category of one for itself with its vertically integrated retail pharmacy-pharmacy benefit manager-clinic model, Walgreens has cast itself in a category of its own: A pharmacy-driven, global health-and-wellness company with the purchasing strength of more than 11,000 stores.

(THE NEWS: Walgreens, Alliance Boots to merge. For the full story, click here)

June 21, 2012

In 2008, an investigation by the Associated Press revealed that drinking water supplies in major cities and metropolitan regions across the country are riddled with pharmaceutical compounds.

In 2008, an investigation by the Associated Press revealed that drinking water supplies in major cities and metropolitan regions across the country are riddled with pharmaceutical compounds. For 41 million Americans, it suggests water with something extra means more than just a slice of lemon, though the quantities of pharmaceutical compounds in the water are too small to constitute a medical dose, according to the report.